A recent study was conducted to show the effect of Oroxylin A in hypoxia-induced cisplatin resistance by inhibiting HIF-1α-mediated xeroderma pigmentosum group C (XPC) transcription [141]. The gene discussed is HIF1A; the disease is xeroderma pigmentosum group C.